Here's what most patients don't know about their medication: Semaglutide same molecule, three very different ceilings: Ozempic (off-label for weight loss): 2.0 mg/week Wegovy: 2.4 mg/week Wegovy HD (FDA-approved March 2026): 7.2 mg/week Tirzepatide (dual GIP/GLP-1 agonist): Zepbound: 15 mg/week A tailored treatment plan means knowing exactly where you are relative to those ceilings and having a provider who adjusts when the biology shifts
Subcutaneous injection to abdomen, thighs, or back of arm, 5-6 days per week in the evening
Evaluation of the genotoxic effect of rutin and quercetin by comet assay and micronucleus test
These peptides offer a safer, more natural option to hormone optimization
When ROS levels exceed the organism's antioxidant defenses, they can lead to oxidative modifications of essential biological macromolecules, tissue damage, and accelerated cell death
Assessment of reproductive tract disease in cats at risk for Tritrichomonas foetus infection